Aptamer Sciences Inc
Aptamer Sciences Inc, a bio venture company, focuses on the Aptamer technology platform for the development of therapeutic and diagnostic platforms. The company's platforms include aptamer discovery, optimization, and the development of therapeutics and diagnostics for cancer and neurological disorders. It offers AlloMAp and Bi-Functional Aptame (BiFAp) platform programs for therapeutics, as well… Read more
Aptamer Sciences Inc (291650) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.029x
Based on the latest financial reports, Aptamer Sciences Inc (291650) has a cash flow conversion efficiency ratio of 0.029x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩576.97 Million) by net assets (₩19.78 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Aptamer Sciences Inc - Cash Flow Conversion Efficiency Trend (2018–2024)
This chart illustrates how Aptamer Sciences Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Aptamer Sciences Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Aptamer Sciences Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Concord Medical Services Holdings
NYSE:CCM
|
0.009x |
|
OY Nofar Energy Ltd
TA:NOFR
|
-0.011x |
|
Yjn Co.,Ltd.
TWO:3191
|
-0.212x |
|
MMP Industries Limited
NSE:MMP
|
0.079x |
|
Star Media Group Bhd
KLSE:6084
|
0.016x |
|
4C Group AB
ST:4C
|
0.019x |
|
Maxeon Solar Technologies Ltd
NASDAQ:MAXN
|
0.148x |
|
Superdong Fast Ferry Kien Giang JSC
VN:SKG
|
N/A |
Annual Cash Flow Conversion Efficiency for Aptamer Sciences Inc (2018–2024)
The table below shows the annual cash flow conversion efficiency of Aptamer Sciences Inc from 2018 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩25.44 Billion | ₩-5.90 Billion | -0.232x | +68.06% |
| 2023-12-31 | ₩15.48 Billion | ₩-11.24 Billion | -0.726x | -267.27% |
| 2022-12-31 | ₩29.22 Billion | ₩-5.78 Billion | -0.198x | -78.98% |
| 2021-12-31 | ₩31.46 Billion | ₩-3.47 Billion | -0.110x | -13.99% |
| 2020-12-31 | ₩35.18 Billion | ₩-3.41 Billion | -0.097x | +72.80% |
| 2019-12-31 | ₩6.94 Billion | ₩-2.47 Billion | -0.356x | -409.15% |
| 2018-12-31 | ₩-18.26 Billion | ₩-2.10 Billion | 0.115x | -- |